0108 Jeito
BioCentury & Getty Images


Closing year with flurry of deals, Tordjman’s Jeito fine-tunes its investment strategy

First investments focus on early-stage European cell and gene therapy

Paris firm returns to J.P. Morgan a year after its launch at the conference with a trio of European cell and gene therapy companies in its portfolio and strategic investors in Sanofi and WuXi AppTec.

Jan 9, 2021 | 4:23 AM GMT

After a quiet first nine months, Paris-based VC Jeito ended 2020 with a trio of investments and a €50 million infusion by Sanofi. And while

Read the full 917 word article

How to gain access

Continue reading with a
two-week free trial.